From Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug:

Headache-conceptual artwork-3d illustration

Headache-conceptual artwork-3d illustration—

Image: iStock/peterschreiber.media

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Whitepaper
How Healthy Are Your Market Access Programs?
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Archbow Consulting

Xconomy on Demand

We offer a number of ways to subscribe for free!